Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (17)

2018

  1. Development and characterisation of chondroitin sulfate- and hyaluronic acid-incorporated sorbitan ester nanoparticles as gene delivery systems

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 125, pp. 85-94

  2. Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation

    International Journal of Pharmaceutics, Vol. 546, Núm. 1-2, pp. 20-30

  3. Targeting liver sinusoidal endothelial cells with miR-20a-loaded nanoparticles reduces murine colon cancer metastasis to the liver

    International Journal of Cancer, Vol. 143, Núm. 3, pp. 709-719

  4. Xanthan gum-functionalised span nanoparticles for gene targeting to endothelial cells

    Colloids and Surfaces B: Biointerfaces, Vol. 170, pp. 411-420

2017

  1. Designing lipid nanoparticles for topical ocular drug delivery

    International Journal of Pharmaceutics, Vol. 532, Núm. 1, pp. 204-217

  2. Gellan gum based physical hydrogels incorporating highly valuable endogen molecules and associating BMP-2 as bone formation platforms

    Carbohydrate Polymers, Vol. 167, pp. 345-355

  3. Nanocarriers for microRNA delivery in cancer medicine

    Biotechnology Advances, Vol. 35, Núm. 3, pp. 350-360

  4. Solid sorbitan esters nanoparticles are efficient and low-cost vehicles for subunit vaccines: Proof of concept with Neisseria meningitidis protein Mip

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 299-306

2016

  1. Span poly-L-arginine nanoparticles are efficient non-viral vectors for PRPF31 gene delivery: An approach of gene therapy to treat retinitis pigmentosa

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 12, Núm. 8, pp. 2251-2260

  2. Structural analysis of nanosystems: Solid Sorbitan esters Nanoparticles (SSN) as a case study

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 104, pp. 189-199

2015

  1. Endogenous Polymers as Biomaterials for Nanoparticulate Gene Therapy

    Handbook of Polymers for Pharmaceutical Technologies (wiley), pp. 237-265

  2. On the biomaterials for nanostructured ocular therapeutics

    Current Organic Chemistry, Vol. 19, Núm. 15, pp. 1443-1459

2014

  1. Anionic nanoparticles based on Span 80 as low-cost, simple and efficient non-viral gene-transfection systems

    International Journal of Pharmaceutics, Vol. 476, Núm. 1, pp. 23-30

  2. Current strategies for DNA therapy based on lipid nanocarriers

    Expert Opinion on Drug Delivery, Vol. 11, Núm. 11, pp. 1721-1731

  3. Nanoparticles based on naturally-occurring biopolymers as versatile delivery platforms for delicate bioactive molecules: An application for ocular gene silencing

    International Journal of Pharmaceutics, Vol. 477, Núm. 1, pp. 12-20

2013

  1. A nanomedicine to treat ocular surface inflammation: Performance on an experimental dry eye murine model

    Gene Therapy, Vol. 20, Núm. 5, pp. 467-477

2011

  1. Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles

    Molecular Pharmaceutics, Vol. 8, Núm. 5, pp. 1783-1788